La. Fitzpatrick et al., DIFFUSE CALCIFICATION IN HUMAN CORONARY-ARTERIES - ASSOCIATION OF OSTEOPONTIN WITH ATHEROSCLEROSIS, The Journal of clinical investigation, 94(4), 1994, pp. 1597-1604
Coronary atherosclerosis is frequently associated with calcification o
f arterial plaque. To understand the mechanisms responsible for the fo
rmation of atherosclerotic calcification, we examined human coronary a
rteries for the presence and extent of mineral. In sections stained sp
ecifically for mineral, staining was diffuse and present in all athero
sclerotic plaques. Hydroxyapatite was not detected in normal coronary
artery sections. Distribution of hydroxyapatite coincided with a simil
ar distribution of calcium detected by a radiodense pattern using cont
act microradiography of the same sections before cytochemical staining
. By energy-dispersive x-ray microanalysis, the chemical composition o
f calcified sites was identical to hydroxyapatite (Ca-10[PO4](6)[OH](2
)), the major inorganic component of bone. Osteopontin is a phosphoryl
ated glycoprotein with known involvement in the formation and calcific
ation of bone and is regulated by local cytokines. Human coronary arte
ry segments (14 normal and 34 atherosclerotic) obtained at autopsy wer
e evaluated immunohistochemically using polyclonal antibodies generate
d against human osteopontin. Immunohistochemistry for osteopontin indi
cated intense, highly specific staining in the outer margins of all di
seased segments at each calcification front; staining was evident thro
ughout the entire plaque. Conversely, arterial segments free of athero
ma and calcification and sections treated with nonimmune serum had no
evidence of positive staining. Osteopontin, a protein involved in mine
ralization is specifically associated with calcific coronary atheroma
and may play an important role in the onset and progression of this di
sease in human coronary arteries. The deposition of noncollagenous pro
teins such as osteopontin may regulate the presence or absence of calc
ification and ultimately alter vessel compliance.